AXON
Price
$525.95
Change
-$9.00 (-1.68%)
Updated
Mar 31 closing price
Capitalization
41.55B
42 days until earnings call
INO
Price
$1.63
Change
-$0.10 (-5.78%)
Updated
Mar 31 closing price
Capitalization
63.43M
Ad is loading...

AXON vs INO

Header iconAXON vs INO Comparison
Open Charts AXON vs INOBanner chart's image
Axon Enterprise
Price$525.95
Change-$9.00 (-1.68%)
Volume$779.46K
Capitalization41.55B
Inovio Pharmaceuticals
Price$1.63
Change-$0.10 (-5.78%)
Volume$992.3K
Capitalization63.43M
AXON vs INO Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. INO commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and INO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (AXON: $525.95 vs. INO: $1.63)
Brand notoriety: AXON: Not notable vs. INO: Notable
AXON represents the Aerospace & Defense, while INO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 87% vs. INO: 143%
Market capitalization -- AXON: $41.55B vs. INO: $63.43M
AXON [@Aerospace & Defense] is valued at $41.55B. INO’s [@Biotechnology] market capitalization is $63.43M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $213.48B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $16.92B. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while INO’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 3 bearish.
  • INO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AXON is a better buy in the short-term than INO.

Price Growth

AXON (@Aerospace & Defense) experienced а -8.13% price change this week, while INO (@Biotechnology) price change was -13.30% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -4.50%. For the same industry, the average monthly price growth was -0.48%, and the average quarterly price growth was +14.83%.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.59%. For the same industry, the average monthly price growth was -10.76%, and the average quarterly price growth was -10.15%.

Reported Earning Dates

AXON is expected to report earnings on May 13, 2025.

INO is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Aerospace & Defense (-4.50% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-8.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($41.5B) has a higher market cap than INO($63.4M). INO YTD gains are higher at: -8.427 vs. AXON (-11.504). AXON has higher annual earnings (EBITDA): 437M vs. INO (-109.89M). AXON has more cash in the bank: 986M vs. INO (84.8M). INO has less debt than AXON: INO (12.4M) vs AXON (722M). AXON has higher revenues than INO: AXON (2.08B) vs INO (203K).
AXONINOAXON / INO
Capitalization41.5B63.4M65,457%
EBITDA437M-109.89M-398%
Gain YTD-11.504-8.427137%
P/E Ratio111.45N/A-
Revenue2.08B203K1,026,108%
Total Cash986M84.8M1,163%
Total Debt722M12.4M5,823%
FUNDAMENTALS RATINGS
AXON vs INO: Fundamental Ratings
AXON
INO
OUTLOOK RATING
1..100
8355
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
13100
SMR RATING
1..100
4798
PRICE GROWTH RATING
1..100
4391
P/E GROWTH RATING
1..100
67100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (60) in the Medical Specialties industry is in the same range as AXON (92) in the Biotechnology industry. This means that INO’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (13) in the Biotechnology industry is significantly better than the same rating for INO (100) in the Medical Specialties industry. This means that AXON’s stock grew significantly faster than INO’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for INO (98) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than INO’s over the last 12 months.

AXON's Price Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for INO (91) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than INO’s over the last 12 months.

AXON's P/E Growth Rating (67) in the Biotechnology industry is somewhat better than the same rating for INO (100) in the Medical Specialties industry. This means that AXON’s stock grew somewhat faster than INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONINO
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASST0.580.06
+11.21%
Asset Entities Inc.
WLKP23.090.01
+0.04%
Westlake Chemical Partners LP
DLTH1.74N/A
N/A
Duluth Holdings
SEB2697.12-14.17
-0.52%
Seaboard Corp
BEKE20.09-0.50
-2.43%
KE Holdings

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
-5.78%
RPTX - INO
57%
Loosely correlated
-6.10%
AXON - INO
53%
Loosely correlated
-1.68%
ARRY - INO
52%
Loosely correlated
-4.13%
ONCO - INO
50%
Loosely correlated
-14.94%
BCYC - INO
48%
Loosely correlated
-5.35%
More